Correlation Between BTG Pactual and Ascendis Pharma

Can any of the company-specific risk be diversified away by investing in both BTG Pactual and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BTG Pactual and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BTG Pactual Logstica and Ascendis Pharma AS, you can compare the effects of market volatilities on BTG Pactual and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BTG Pactual with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BTG Pactual and Ascendis Pharma.

Diversification Opportunities for BTG Pactual and Ascendis Pharma

-0.27

Correlation Coefficient

BTG Pactual  Ascendis Pharma

Very good diversification

The 3 months correlation between BTG and Ascendis is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding BTG Pactual Logstica and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and BTG Pactual is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BTG Pactual Logstica are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of BTG Pactual i.e., BTG Pactual and Ascendis Pharma go up and down completely randomly.

Pair Corralation between BTG Pactual and Ascendis Pharma

Assuming the 90 days trading horizon BTG Pactual Logstica is expected to under-perform the Ascendis Pharma. But the fund apears to be less risky and, when comparing its historical volatility, BTG Pactual Logstica is 1.19 times less risky than Ascendis Pharma. The fund trades about -0.05 of its potential returns per unit of risk. The Ascendis Pharma AS is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  5,100  in Ascendis Pharma AS on October 7, 2024 and sell it today you would earn a total of  582.00  from holding Ascendis Pharma AS or generate 11.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

BTG Pactual Logstica  vs.  Ascendis Pharma AS

BTG Pactual Logstica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BTG Pactual Logstica has generated negative risk-adjusted returns adding no value to fund investors. Despite somewhat strong essential indicators, BTG Pactual is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ascendis Pharma AS

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ascendis Pharma may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with BTG Pactual and Ascendis Pharma

The main advantage of trading using opposite BTG Pactual and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BTG Pactual position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.

The idea behind BTG Pactual Logstica and Ascendis Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.